论文部分内容阅读
肝内胆管癌(intrahepatic cholangiocarcinoma,ICC)是肝脏肿瘤中发病率仅次于肝细胞肝癌的原发恶性肿瘤,起源于肝内二级胆管及其以上肝内胆管分支的上皮细胞。对于考虑合并血管侵犯、存在淋巴结转移的病人,治疗方案的选择尚无明确指南建议~([1])。浙江大学医学院附属第二医院收治1例ICC病人,运用循证决策方法制定治疗策略。现报告如下。1病历简介病人男性,69岁,因“进行性消瘦1年,发现肝脏占位性
Intrahepatic cholangiocarcinoma (ICC) is the primary malignant tumor with the second highest incidence in hepatocellular carcinoma, which originated from the intrahepatic bile duct and the epithelium above its intrahepatic bile duct. There is no clear guideline for the selection of treatment options for patients considering a combination of vascular invasion and presence of lymph node metastases ~ ([1]). Second Affiliated Hospital of Zhejiang University School of Medicine admitted to a case of ICC patients, the use of evidence-based decision-making approach to develop treatment strategies. The report is as follows. 1 case history Male patient, 69 years old, due to ”progressive weight loss for 1 year, found that liver space